CSIR Central

Triazino indole-Quinoline hybrid: A novel approach to Antileishmanial agents

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Sharma, Rashmi
Pandey, A K
Shivahare, Rahul
Srivastava, Khushboo
Gupta, Suman
Chauhan, P M S
 
Date 2014-04-25T07:41:05Z
2014-04-25T07:41:05Z
2014
 
Identifier Bioorganic & Medicinal Chemistry Letters, 2014, 24(1), 298-301
http://hdl.handle.net/123456789/1214
 
Description A novel series of 1,2,4-triazino-[5,6b]indole-3-thione covalently linked to 7-chloro-4-aminoquinoline have been synthesized and evaluated for their in vitro activity against extracellular promastigote and intracellular amastigote form of Leishmania donovani. Among all tested compounds, compound 7a and 7b was found to be the most active with IC50 values 1.11, 0.36 μM and selectivity index (SI) values 67, >1111 respectively against amastigote form of L. donovani which is several folds more potent than the standard drugs, miltefosine (IC50 = 8.10 µM, SI = 7) and sodium stibo-gluconate (IC50 = 54.60 µM, SI = >7).
 
Format 196155 bytes
application/pdf
 
Language en
 
Relation CSIR-CDRI Communication No. 8565
 
Subject Antileishmanial
Hybrid
In vitro
Leishmania donovani
Quinoline
Triazino-indole
 
Title Triazino indole-Quinoline hybrid: A novel approach to Antileishmanial agents
 
Type Article